To navigate a changing industry landscape, many big pharma companies are scaling up their sustainable procurement programs and collaborating with peers and even competitors to increase their depth and breadth of supply chain visibility. GlaxoSmithKline, Teva and Takeda recently established the Responsible Health Initiative (RHI), an industry group designed to leverage collaboration and technology to improve transparency, efficiency and sustainability within the global health supply chain.
About the Author
EcoVadis is a purpose-driven company dedicated to embedding sustainability intelligence into every business decision worldwide. With global, trusted and actionable ratings, businesses of all sizes rely on EcoVadis’ detailed insights to comply with ESG regulations, reduce GHG emissions, and improve the sustainability performance of their business and value chain across 220 industries in 180 countries. Leaders like Johnson & Johnson, L’Oréal, Unilever, Bridgestone, BASF and JPMorgan are among 150,000+ businesses that use EcoVadis ratings, risk, and carbon management tools and e-learning platform to accelerate their journey toward resilience, sustainable growth and positive impact worldwide.
Follow on Linkedin
Visit Website
More Content by EcoVadis EN
